nodes	percent_of_prediction	percent_of_DWPC	metapath
Etravirine—CYP3A4—breast cancer	0.15	0.546	CbGaD
Etravirine—ABCB1—breast cancer	0.125	0.454	CbGaD
Etravirine—CYP2C9—Anastrozole—breast cancer	0.0334	0.0715	CbGbCtD
Etravirine—ABCB1—Toremifene—breast cancer	0.0297	0.0635	CbGbCtD
Etravirine—CYP2C19—Lapatinib—breast cancer	0.0268	0.0574	CbGbCtD
Etravirine—CYP3A4—Exemestane—breast cancer	0.0256	0.0549	CbGbCtD
Etravirine—CYP2C9—Idarubicin—breast cancer	0.0253	0.0542	CbGbCtD
Etravirine—CYP3A4—Letrozole—breast cancer	0.0218	0.0467	CbGbCtD
Etravirine—ABCB1—Lapatinib—breast cancer	0.0216	0.0463	CbGbCtD
Etravirine—CYP3A4—Anastrozole—breast cancer	0.0194	0.0416	CbGbCtD
Etravirine—CYP3A4—Toremifene—breast cancer	0.0178	0.038	CbGbCtD
Etravirine—CYP3A4—Fulvestrant—breast cancer	0.0165	0.0354	CbGbCtD
Etravirine—CYP3A4—Thiotepa—breast cancer	0.0147	0.0315	CbGbCtD
Etravirine—CYP2C9—Capecitabine—breast cancer	0.0139	0.0297	CbGbCtD
Etravirine—CYP3A4—Ixabepilone—breast cancer	0.0135	0.0288	CbGbCtD
Etravirine—CYP2C19—Tamoxifen—breast cancer	0.0134	0.0287	CbGbCtD
Etravirine—CYP3A4—Lapatinib—breast cancer	0.013	0.0278	CbGbCtD
Etravirine—ABCB1—Vinorelbine—breast cancer	0.012	0.0257	CbGbCtD
Etravirine—CYP2C9—Tamoxifen—breast cancer	0.0112	0.0239	CbGbCtD
Etravirine—ABCB1—Tamoxifen—breast cancer	0.0108	0.0232	CbGbCtD
Etravirine—ABCB1—Mitoxantrone—breast cancer	0.0106	0.0226	CbGbCtD
Etravirine—CYP3A4—Raloxifene—breast cancer	0.00983	0.021	CbGbCtD
Etravirine—ABCB1—Gemcitabine—breast cancer	0.00934	0.02	CbGbCtD
Etravirine—CYP2C9—Paclitaxel—breast cancer	0.00869	0.0186	CbGbCtD
Etravirine—ABCB1—Paclitaxel—breast cancer	0.00844	0.0181	CbGbCtD
Etravirine—ABCB1—Irinotecan—breast cancer	0.00832	0.0178	CbGbCtD
Etravirine—CYP2C9—Fluorouracil—breast cancer	0.00823	0.0176	CbGbCtD
Etravirine—ABCB1—Vinblastine—breast cancer	0.0074	0.0158	CbGbCtD
Etravirine—CYP3A4—Vinorelbine—breast cancer	0.00719	0.0154	CbGbCtD
Etravirine—CYP3A4—Tamoxifen—breast cancer	0.00649	0.0139	CbGbCtD
Etravirine—CYP3A4—Mitoxantrone—breast cancer	0.00633	0.0136	CbGbCtD
Etravirine—ABCB1—Docetaxel—breast cancer	0.0061	0.0131	CbGbCtD
Etravirine—CYP3A4—Paclitaxel—breast cancer	0.00505	0.0108	CbGbCtD
Etravirine—CYP3A4—Irinotecan—breast cancer	0.00499	0.0107	CbGbCtD
Etravirine—ABCB1—Doxorubicin—breast cancer	0.00455	0.00973	CbGbCtD
Etravirine—CYP3A4—Vinblastine—breast cancer	0.00443	0.00949	CbGbCtD
Etravirine—ABCB1—Methotrexate—breast cancer	0.0044	0.00942	CbGbCtD
Etravirine—CYP3A4—Docetaxel—breast cancer	0.00365	0.00782	CbGbCtD
Etravirine—CYP3A4—Doxorubicin—breast cancer	0.00272	0.00583	CbGbCtD
Etravirine—Rilpivirine—SLCO1B1—breast cancer	0.00237	0.545	CrCbGaD
Etravirine—Rilpivirine—ABCG2—breast cancer	0.00103	0.237	CrCbGaD
Etravirine—Rilpivirine—CYP3A4—breast cancer	0.000515	0.119	CrCbGaD
Etravirine—Rilpivirine—ABCB1—breast cancer	0.000429	0.0988	CrCbGaD
Etravirine—Stevens-Johnson syndrome—Doxorubicin—breast cancer	5.21e-05	0.000289	CcSEcCtD
Etravirine—Gastrointestinal pain—Paclitaxel—breast cancer	5.18e-05	0.000287	CcSEcCtD
Etravirine—Diarrhoea—Gemcitabine—breast cancer	5.18e-05	0.000287	CcSEcCtD
Etravirine—Renal failure—Doxorubicin—breast cancer	5.16e-05	0.000286	CcSEcCtD
Etravirine—Infection—Capecitabine—breast cancer	5.16e-05	0.000286	CcSEcCtD
Etravirine—Erythema multiforme—Methotrexate—breast cancer	5.15e-05	0.000286	CcSEcCtD
Etravirine—Neuropathy peripheral—Doxorubicin—breast cancer	5.15e-05	0.000286	CcSEcCtD
Etravirine—Dizziness—Irinotecan—breast cancer	5.14e-05	0.000285	CcSEcCtD
Etravirine—Stomatitis—Doxorubicin—breast cancer	5.12e-05	0.000284	CcSEcCtD
Etravirine—Anorexia—Docetaxel—breast cancer	5.12e-05	0.000284	CcSEcCtD
Etravirine—Shock—Capecitabine—breast cancer	5.11e-05	0.000284	CcSEcCtD
Etravirine—Conjunctivitis—Doxorubicin—breast cancer	5.11e-05	0.000283	CcSEcCtD
Etravirine—Nervous system disorder—Capecitabine—breast cancer	5.1e-05	0.000283	CcSEcCtD
Etravirine—Hepatitis—Epirubicin—breast cancer	5.1e-05	0.000283	CcSEcCtD
Etravirine—Eye disorder—Methotrexate—breast cancer	5.09e-05	0.000282	CcSEcCtD
Etravirine—Diarrhoea—Fluorouracil—breast cancer	5.09e-05	0.000282	CcSEcCtD
Etravirine—Thrombocytopenia—Capecitabine—breast cancer	5.09e-05	0.000282	CcSEcCtD
Etravirine—Hypoaesthesia—Epirubicin—breast cancer	5.07e-05	0.000281	CcSEcCtD
Etravirine—Cardiac disorder—Methotrexate—breast cancer	5.05e-05	0.00028	CcSEcCtD
Etravirine—Skin disorder—Capecitabine—breast cancer	5.05e-05	0.00028	CcSEcCtD
Etravirine—Urinary tract disorder—Epirubicin—breast cancer	5.03e-05	0.000279	CcSEcCtD
Etravirine—Hyperhidrosis—Capecitabine—breast cancer	5.03e-05	0.000279	CcSEcCtD
Etravirine—Connective tissue disorder—Epirubicin—breast cancer	5.01e-05	0.000278	CcSEcCtD
Etravirine—Body temperature increased—Paclitaxel—breast cancer	5.01e-05	0.000278	CcSEcCtD
Etravirine—Abdominal pain—Paclitaxel—breast cancer	5.01e-05	0.000278	CcSEcCtD
Etravirine—Urethral disorder—Epirubicin—breast cancer	5e-05	0.000277	CcSEcCtD
Etravirine—Hepatobiliary disease—Doxorubicin—breast cancer	4.97e-05	0.000276	CcSEcCtD
Etravirine—Anorexia—Capecitabine—breast cancer	4.95e-05	0.000275	CcSEcCtD
Etravirine—Angiopathy—Methotrexate—breast cancer	4.94e-05	0.000274	CcSEcCtD
Etravirine—Vomiting—Mitoxantrone—breast cancer	4.94e-05	0.000274	CcSEcCtD
Etravirine—Vomiting—Irinotecan—breast cancer	4.94e-05	0.000274	CcSEcCtD
Etravirine—Immune system disorder—Methotrexate—breast cancer	4.92e-05	0.000273	CcSEcCtD
Etravirine—Dizziness—Fluorouracil—breast cancer	4.92e-05	0.000273	CcSEcCtD
Etravirine—Mediastinal disorder—Methotrexate—breast cancer	4.91e-05	0.000272	CcSEcCtD
Etravirine—Rash—Irinotecan—breast cancer	4.9e-05	0.000272	CcSEcCtD
Etravirine—Rash—Mitoxantrone—breast cancer	4.9e-05	0.000272	CcSEcCtD
Etravirine—Dermatitis—Mitoxantrone—breast cancer	4.89e-05	0.000271	CcSEcCtD
Etravirine—Dermatitis—Irinotecan—breast cancer	4.89e-05	0.000271	CcSEcCtD
Etravirine—Headache—Irinotecan—breast cancer	4.87e-05	0.00027	CcSEcCtD
Etravirine—Headache—Mitoxantrone—breast cancer	4.87e-05	0.00027	CcSEcCtD
Etravirine—Insomnia—Docetaxel—breast cancer	4.86e-05	0.000269	CcSEcCtD
Etravirine—Paraesthesia—Docetaxel—breast cancer	4.82e-05	0.000267	CcSEcCtD
Etravirine—Erythema multiforme—Epirubicin—breast cancer	4.82e-05	0.000267	CcSEcCtD
Etravirine—Vomiting—Gemcitabine—breast cancer	4.81e-05	0.000267	CcSEcCtD
Etravirine—Somnolence—Docetaxel—breast cancer	4.77e-05	0.000265	CcSEcCtD
Etravirine—Mental disorder—Methotrexate—breast cancer	4.77e-05	0.000265	CcSEcCtD
Etravirine—Rash—Gemcitabine—breast cancer	4.77e-05	0.000265	CcSEcCtD
Etravirine—Dermatitis—Gemcitabine—breast cancer	4.77e-05	0.000264	CcSEcCtD
Etravirine—Eye disorder—Epirubicin—breast cancer	4.76e-05	0.000264	CcSEcCtD
Etravirine—Malnutrition—Methotrexate—breast cancer	4.74e-05	0.000263	CcSEcCtD
Etravirine—Headache—Gemcitabine—breast cancer	4.74e-05	0.000263	CcSEcCtD
Etravirine—Cardiac disorder—Epirubicin—breast cancer	4.73e-05	0.000262	CcSEcCtD
Etravirine—Vomiting—Fluorouracil—breast cancer	4.73e-05	0.000262	CcSEcCtD
Etravirine—Hepatitis—Doxorubicin—breast cancer	4.72e-05	0.000262	CcSEcCtD
Etravirine—Insomnia—Capecitabine—breast cancer	4.7e-05	0.000261	CcSEcCtD
Etravirine—Hypoaesthesia—Doxorubicin—breast cancer	4.69e-05	0.00026	CcSEcCtD
Etravirine—Rash—Fluorouracil—breast cancer	4.69e-05	0.00026	CcSEcCtD
Etravirine—Dermatitis—Fluorouracil—breast cancer	4.69e-05	0.00026	CcSEcCtD
Etravirine—Paraesthesia—Capecitabine—breast cancer	4.67e-05	0.000259	CcSEcCtD
Etravirine—Decreased appetite—Docetaxel—breast cancer	4.67e-05	0.000259	CcSEcCtD
Etravirine—Hypersensitivity—Paclitaxel—breast cancer	4.67e-05	0.000259	CcSEcCtD
Etravirine—Headache—Fluorouracil—breast cancer	4.66e-05	0.000258	CcSEcCtD
Etravirine—Urinary tract disorder—Doxorubicin—breast cancer	4.66e-05	0.000258	CcSEcCtD
Etravirine—Gastrointestinal disorder—Docetaxel—breast cancer	4.64e-05	0.000257	CcSEcCtD
Etravirine—Connective tissue disorder—Doxorubicin—breast cancer	4.63e-05	0.000257	CcSEcCtD
Etravirine—Fatigue—Docetaxel—breast cancer	4.63e-05	0.000257	CcSEcCtD
Etravirine—Angiopathy—Epirubicin—breast cancer	4.62e-05	0.000256	CcSEcCtD
Etravirine—Urethral disorder—Doxorubicin—breast cancer	4.62e-05	0.000256	CcSEcCtD
Etravirine—Nausea—Mitoxantrone—breast cancer	4.61e-05	0.000256	CcSEcCtD
Etravirine—Nausea—Irinotecan—breast cancer	4.61e-05	0.000256	CcSEcCtD
Etravirine—Immune system disorder—Epirubicin—breast cancer	4.6e-05	0.000255	CcSEcCtD
Etravirine—Mediastinal disorder—Epirubicin—breast cancer	4.59e-05	0.000255	CcSEcCtD
Etravirine—Constipation—Docetaxel—breast cancer	4.59e-05	0.000255	CcSEcCtD
Etravirine—Pain—Docetaxel—breast cancer	4.59e-05	0.000255	CcSEcCtD
Etravirine—Asthenia—Paclitaxel—breast cancer	4.54e-05	0.000252	CcSEcCtD
Etravirine—Decreased appetite—Capecitabine—breast cancer	4.52e-05	0.000251	CcSEcCtD
Etravirine—Nausea—Gemcitabine—breast cancer	4.49e-05	0.000249	CcSEcCtD
Etravirine—Gastrointestinal disorder—Capecitabine—breast cancer	4.49e-05	0.000249	CcSEcCtD
Etravirine—Fatigue—Capecitabine—breast cancer	4.48e-05	0.000249	CcSEcCtD
Etravirine—Vision blurred—Methotrexate—breast cancer	4.47e-05	0.000248	CcSEcCtD
Etravirine—Mental disorder—Epirubicin—breast cancer	4.47e-05	0.000248	CcSEcCtD
Etravirine—Erythema multiforme—Doxorubicin—breast cancer	4.46e-05	0.000247	CcSEcCtD
Etravirine—Pain—Capecitabine—breast cancer	4.45e-05	0.000247	CcSEcCtD
Etravirine—Constipation—Capecitabine—breast cancer	4.45e-05	0.000247	CcSEcCtD
Etravirine—Malnutrition—Epirubicin—breast cancer	4.44e-05	0.000246	CcSEcCtD
Etravirine—Feeling abnormal—Docetaxel—breast cancer	4.42e-05	0.000245	CcSEcCtD
Etravirine—Nausea—Fluorouracil—breast cancer	4.42e-05	0.000245	CcSEcCtD
Etravirine—Eye disorder—Doxorubicin—breast cancer	4.41e-05	0.000244	CcSEcCtD
Etravirine—Ill-defined disorder—Methotrexate—breast cancer	4.4e-05	0.000244	CcSEcCtD
Etravirine—Gastrointestinal pain—Docetaxel—breast cancer	4.39e-05	0.000244	CcSEcCtD
Etravirine—Anaemia—Methotrexate—breast cancer	4.38e-05	0.000243	CcSEcCtD
Etravirine—Cardiac disorder—Doxorubicin—breast cancer	4.38e-05	0.000243	CcSEcCtD
Etravirine—Flatulence—Epirubicin—breast cancer	4.37e-05	0.000243	CcSEcCtD
Etravirine—Tension—Epirubicin—breast cancer	4.35e-05	0.000241	CcSEcCtD
Etravirine—Diarrhoea—Paclitaxel—breast cancer	4.33e-05	0.00024	CcSEcCtD
Etravirine—Nervousness—Epirubicin—breast cancer	4.31e-05	0.000239	CcSEcCtD
Etravirine—Feeling abnormal—Capecitabine—breast cancer	4.28e-05	0.000238	CcSEcCtD
Etravirine—Angiopathy—Doxorubicin—breast cancer	4.28e-05	0.000237	CcSEcCtD
Etravirine—Malaise—Methotrexate—breast cancer	4.28e-05	0.000237	CcSEcCtD
Etravirine—Immune system disorder—Doxorubicin—breast cancer	4.26e-05	0.000236	CcSEcCtD
Etravirine—Vertigo—Methotrexate—breast cancer	4.26e-05	0.000236	CcSEcCtD
Etravirine—Gastrointestinal pain—Capecitabine—breast cancer	4.25e-05	0.000236	CcSEcCtD
Etravirine—Mediastinal disorder—Doxorubicin—breast cancer	4.25e-05	0.000236	CcSEcCtD
Etravirine—Body temperature increased—Docetaxel—breast cancer	4.24e-05	0.000235	CcSEcCtD
Etravirine—Abdominal pain—Docetaxel—breast cancer	4.24e-05	0.000235	CcSEcCtD
Etravirine—Dizziness—Paclitaxel—breast cancer	4.19e-05	0.000232	CcSEcCtD
Etravirine—Vision blurred—Epirubicin—breast cancer	4.18e-05	0.000232	CcSEcCtD
Etravirine—Mental disorder—Doxorubicin—breast cancer	4.13e-05	0.000229	CcSEcCtD
Etravirine—Ill-defined disorder—Epirubicin—breast cancer	4.12e-05	0.000228	CcSEcCtD
Etravirine—Body temperature increased—Capecitabine—breast cancer	4.11e-05	0.000228	CcSEcCtD
Etravirine—Abdominal pain—Capecitabine—breast cancer	4.11e-05	0.000228	CcSEcCtD
Etravirine—Convulsion—Methotrexate—breast cancer	4.11e-05	0.000228	CcSEcCtD
Etravirine—Malnutrition—Doxorubicin—breast cancer	4.11e-05	0.000228	CcSEcCtD
Etravirine—Anaemia—Epirubicin—breast cancer	4.1e-05	0.000227	CcSEcCtD
Etravirine—Flatulence—Doxorubicin—breast cancer	4.05e-05	0.000224	CcSEcCtD
Etravirine—Tension—Doxorubicin—breast cancer	4.03e-05	0.000223	CcSEcCtD
Etravirine—Vomiting—Paclitaxel—breast cancer	4.03e-05	0.000223	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	4.01e-05	0.000222	CcSEcCtD
Etravirine—Malaise—Epirubicin—breast cancer	4e-05	0.000222	CcSEcCtD
Etravirine—Rash—Paclitaxel—breast cancer	3.99e-05	0.000222	CcSEcCtD
Etravirine—Dermatitis—Paclitaxel—breast cancer	3.99e-05	0.000221	CcSEcCtD
Etravirine—Discomfort—Methotrexate—breast cancer	3.99e-05	0.000221	CcSEcCtD
Etravirine—Nervousness—Doxorubicin—breast cancer	3.99e-05	0.000221	CcSEcCtD
Etravirine—Vertigo—Epirubicin—breast cancer	3.99e-05	0.000221	CcSEcCtD
Etravirine—Syncope—Epirubicin—breast cancer	3.98e-05	0.000221	CcSEcCtD
Etravirine—Headache—Paclitaxel—breast cancer	3.97e-05	0.00022	CcSEcCtD
Etravirine—Hypersensitivity—Docetaxel—breast cancer	3.96e-05	0.000219	CcSEcCtD
Etravirine—Confusional state—Methotrexate—breast cancer	3.9e-05	0.000216	CcSEcCtD
Etravirine—Loss of consciousness—Epirubicin—breast cancer	3.9e-05	0.000216	CcSEcCtD
Etravirine—Vision blurred—Doxorubicin—breast cancer	3.87e-05	0.000215	CcSEcCtD
Etravirine—Asthenia—Docetaxel—breast cancer	3.85e-05	0.000214	CcSEcCtD
Etravirine—Convulsion—Epirubicin—breast cancer	3.84e-05	0.000213	CcSEcCtD
Etravirine—Infection—Methotrexate—breast cancer	3.84e-05	0.000213	CcSEcCtD
Etravirine—Hypertension—Epirubicin—breast cancer	3.83e-05	0.000212	CcSEcCtD
Etravirine—Hypersensitivity—Capecitabine—breast cancer	3.83e-05	0.000212	CcSEcCtD
Etravirine—Ill-defined disorder—Doxorubicin—breast cancer	3.81e-05	0.000211	CcSEcCtD
Etravirine—Nervous system disorder—Methotrexate—breast cancer	3.79e-05	0.00021	CcSEcCtD
Etravirine—Anaemia—Doxorubicin—breast cancer	3.79e-05	0.00021	CcSEcCtD
Etravirine—Thrombocytopenia—Methotrexate—breast cancer	3.79e-05	0.00021	CcSEcCtD
Etravirine—Anxiety—Epirubicin—breast cancer	3.76e-05	0.000209	CcSEcCtD
Etravirine—Nausea—Paclitaxel—breast cancer	3.76e-05	0.000209	CcSEcCtD
Etravirine—Skin disorder—Methotrexate—breast cancer	3.76e-05	0.000208	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	3.75e-05	0.000208	CcSEcCtD
Etravirine—Hyperhidrosis—Methotrexate—breast cancer	3.74e-05	0.000207	CcSEcCtD
Etravirine—Discomfort—Epirubicin—breast cancer	3.73e-05	0.000207	CcSEcCtD
Etravirine—Asthenia—Capecitabine—breast cancer	3.73e-05	0.000207	CcSEcCtD
Etravirine—Malaise—Doxorubicin—breast cancer	3.7e-05	0.000205	CcSEcCtD
Etravirine—Dry mouth—Epirubicin—breast cancer	3.69e-05	0.000205	CcSEcCtD
Etravirine—Vertigo—Doxorubicin—breast cancer	3.69e-05	0.000205	CcSEcCtD
Etravirine—Anorexia—Methotrexate—breast cancer	3.69e-05	0.000205	CcSEcCtD
Etravirine—Syncope—Doxorubicin—breast cancer	3.68e-05	0.000204	CcSEcCtD
Etravirine—Diarrhoea—Docetaxel—breast cancer	3.67e-05	0.000204	CcSEcCtD
Etravirine—Confusional state—Epirubicin—breast cancer	3.65e-05	0.000203	CcSEcCtD
Etravirine—Loss of consciousness—Doxorubicin—breast cancer	3.61e-05	0.0002	CcSEcCtD
Etravirine—Infection—Epirubicin—breast cancer	3.6e-05	0.0002	CcSEcCtD
Etravirine—Shock—Epirubicin—breast cancer	3.56e-05	0.000198	CcSEcCtD
Etravirine—Convulsion—Doxorubicin—breast cancer	3.56e-05	0.000197	CcSEcCtD
Etravirine—Diarrhoea—Capecitabine—breast cancer	3.56e-05	0.000197	CcSEcCtD
Etravirine—Nervous system disorder—Epirubicin—breast cancer	3.55e-05	0.000197	CcSEcCtD
Etravirine—Dizziness—Docetaxel—breast cancer	3.55e-05	0.000197	CcSEcCtD
Etravirine—Thrombocytopenia—Epirubicin—breast cancer	3.55e-05	0.000197	CcSEcCtD
Etravirine—Hypertension—Doxorubicin—breast cancer	3.54e-05	0.000197	CcSEcCtD
Etravirine—Skin disorder—Epirubicin—breast cancer	3.52e-05	0.000195	CcSEcCtD
Etravirine—Hyperhidrosis—Epirubicin—breast cancer	3.5e-05	0.000194	CcSEcCtD
Etravirine—Insomnia—Methotrexate—breast cancer	3.5e-05	0.000194	CcSEcCtD
Etravirine—Anxiety—Doxorubicin—breast cancer	3.48e-05	0.000193	CcSEcCtD
Etravirine—Paraesthesia—Methotrexate—breast cancer	3.47e-05	0.000193	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	3.47e-05	0.000193	CcSEcCtD
Etravirine—Discomfort—Doxorubicin—breast cancer	3.45e-05	0.000192	CcSEcCtD
Etravirine—Anorexia—Epirubicin—breast cancer	3.45e-05	0.000191	CcSEcCtD
Etravirine—Somnolence—Methotrexate—breast cancer	3.44e-05	0.000191	CcSEcCtD
Etravirine—Dizziness—Capecitabine—breast cancer	3.44e-05	0.000191	CcSEcCtD
Etravirine—Dry mouth—Doxorubicin—breast cancer	3.42e-05	0.00019	CcSEcCtD
Etravirine—Vomiting—Docetaxel—breast cancer	3.41e-05	0.000189	CcSEcCtD
Etravirine—Rash—Docetaxel—breast cancer	3.39e-05	0.000188	CcSEcCtD
Etravirine—Dermatitis—Docetaxel—breast cancer	3.38e-05	0.000188	CcSEcCtD
Etravirine—Confusional state—Doxorubicin—breast cancer	3.38e-05	0.000187	CcSEcCtD
Etravirine—Decreased appetite—Methotrexate—breast cancer	3.36e-05	0.000187	CcSEcCtD
Etravirine—Headache—Docetaxel—breast cancer	3.36e-05	0.000187	CcSEcCtD
Etravirine—Gastrointestinal disorder—Methotrexate—breast cancer	3.34e-05	0.000185	CcSEcCtD
Etravirine—Fatigue—Methotrexate—breast cancer	3.34e-05	0.000185	CcSEcCtD
Etravirine—Infection—Doxorubicin—breast cancer	3.33e-05	0.000185	CcSEcCtD
Etravirine—Pain—Methotrexate—breast cancer	3.31e-05	0.000184	CcSEcCtD
Etravirine—Vomiting—Capecitabine—breast cancer	3.3e-05	0.000183	CcSEcCtD
Etravirine—Shock—Doxorubicin—breast cancer	3.3e-05	0.000183	CcSEcCtD
Etravirine—Nervous system disorder—Doxorubicin—breast cancer	3.29e-05	0.000182	CcSEcCtD
Etravirine—Thrombocytopenia—Doxorubicin—breast cancer	3.28e-05	0.000182	CcSEcCtD
Etravirine—Rash—Capecitabine—breast cancer	3.28e-05	0.000182	CcSEcCtD
Etravirine—Insomnia—Epirubicin—breast cancer	3.28e-05	0.000182	CcSEcCtD
Etravirine—Dermatitis—Capecitabine—breast cancer	3.27e-05	0.000182	CcSEcCtD
Etravirine—Headache—Capecitabine—breast cancer	3.26e-05	0.000181	CcSEcCtD
Etravirine—Skin disorder—Doxorubicin—breast cancer	3.25e-05	0.000181	CcSEcCtD
Etravirine—Paraesthesia—Epirubicin—breast cancer	3.25e-05	0.00018	CcSEcCtD
Etravirine—Hyperhidrosis—Doxorubicin—breast cancer	3.24e-05	0.00018	CcSEcCtD
Etravirine—Somnolence—Epirubicin—breast cancer	3.22e-05	0.000179	CcSEcCtD
Etravirine—Anorexia—Doxorubicin—breast cancer	3.19e-05	0.000177	CcSEcCtD
Etravirine—Nausea—Docetaxel—breast cancer	3.19e-05	0.000177	CcSEcCtD
Etravirine—Feeling abnormal—Methotrexate—breast cancer	3.19e-05	0.000177	CcSEcCtD
Etravirine—Gastrointestinal pain—Methotrexate—breast cancer	3.16e-05	0.000176	CcSEcCtD
Etravirine—Decreased appetite—Epirubicin—breast cancer	3.15e-05	0.000175	CcSEcCtD
Etravirine—Gastrointestinal disorder—Epirubicin—breast cancer	3.13e-05	0.000173	CcSEcCtD
Etravirine—Fatigue—Epirubicin—breast cancer	3.12e-05	0.000173	CcSEcCtD
Etravirine—Constipation—Epirubicin—breast cancer	3.1e-05	0.000172	CcSEcCtD
Etravirine—Pain—Epirubicin—breast cancer	3.1e-05	0.000172	CcSEcCtD
Etravirine—Nausea—Capecitabine—breast cancer	3.09e-05	0.000171	CcSEcCtD
Etravirine—Body temperature increased—Methotrexate—breast cancer	3.06e-05	0.00017	CcSEcCtD
Etravirine—Abdominal pain—Methotrexate—breast cancer	3.06e-05	0.00017	CcSEcCtD
Etravirine—Insomnia—Doxorubicin—breast cancer	3.03e-05	0.000168	CcSEcCtD
Etravirine—Paraesthesia—Doxorubicin—breast cancer	3.01e-05	0.000167	CcSEcCtD
Etravirine—Feeling abnormal—Epirubicin—breast cancer	2.98e-05	0.000166	CcSEcCtD
Etravirine—Somnolence—Doxorubicin—breast cancer	2.98e-05	0.000165	CcSEcCtD
Etravirine—Gastrointestinal pain—Epirubicin—breast cancer	2.96e-05	0.000164	CcSEcCtD
Etravirine—Decreased appetite—Doxorubicin—breast cancer	2.91e-05	0.000162	CcSEcCtD
Etravirine—Gastrointestinal disorder—Doxorubicin—breast cancer	2.89e-05	0.00016	CcSEcCtD
Etravirine—Fatigue—Doxorubicin—breast cancer	2.89e-05	0.00016	CcSEcCtD
Etravirine—Pain—Doxorubicin—breast cancer	2.87e-05	0.000159	CcSEcCtD
Etravirine—Constipation—Doxorubicin—breast cancer	2.87e-05	0.000159	CcSEcCtD
Etravirine—Body temperature increased—Epirubicin—breast cancer	2.86e-05	0.000159	CcSEcCtD
Etravirine—Abdominal pain—Epirubicin—breast cancer	2.86e-05	0.000159	CcSEcCtD
Etravirine—Hypersensitivity—Methotrexate—breast cancer	2.85e-05	0.000158	CcSEcCtD
Etravirine—Asthenia—Methotrexate—breast cancer	2.78e-05	0.000154	CcSEcCtD
Etravirine—Feeling abnormal—Doxorubicin—breast cancer	2.76e-05	0.000153	CcSEcCtD
Etravirine—Gastrointestinal pain—Doxorubicin—breast cancer	2.74e-05	0.000152	CcSEcCtD
Etravirine—Hypersensitivity—Epirubicin—breast cancer	2.67e-05	0.000148	CcSEcCtD
Etravirine—Abdominal pain—Doxorubicin—breast cancer	2.65e-05	0.000147	CcSEcCtD
Etravirine—Body temperature increased—Doxorubicin—breast cancer	2.65e-05	0.000147	CcSEcCtD
Etravirine—Diarrhoea—Methotrexate—breast cancer	2.65e-05	0.000147	CcSEcCtD
Etravirine—Asthenia—Epirubicin—breast cancer	2.6e-05	0.000144	CcSEcCtD
Etravirine—Dizziness—Methotrexate—breast cancer	2.56e-05	0.000142	CcSEcCtD
Etravirine—Diarrhoea—Epirubicin—breast cancer	2.48e-05	0.000137	CcSEcCtD
Etravirine—Hypersensitivity—Doxorubicin—breast cancer	2.47e-05	0.000137	CcSEcCtD
Etravirine—Vomiting—Methotrexate—breast cancer	2.46e-05	0.000136	CcSEcCtD
Etravirine—Rash—Methotrexate—breast cancer	2.44e-05	0.000135	CcSEcCtD
Etravirine—Dermatitis—Methotrexate—breast cancer	2.44e-05	0.000135	CcSEcCtD
Etravirine—Headache—Methotrexate—breast cancer	2.42e-05	0.000134	CcSEcCtD
Etravirine—Asthenia—Doxorubicin—breast cancer	2.4e-05	0.000133	CcSEcCtD
Etravirine—Dizziness—Epirubicin—breast cancer	2.39e-05	0.000133	CcSEcCtD
Etravirine—Vomiting—Epirubicin—breast cancer	2.3e-05	0.000128	CcSEcCtD
Etravirine—Nausea—Methotrexate—breast cancer	2.3e-05	0.000127	CcSEcCtD
Etravirine—Diarrhoea—Doxorubicin—breast cancer	2.29e-05	0.000127	CcSEcCtD
Etravirine—Rash—Epirubicin—breast cancer	2.28e-05	0.000127	CcSEcCtD
Etravirine—Dermatitis—Epirubicin—breast cancer	2.28e-05	0.000127	CcSEcCtD
Etravirine—Headache—Epirubicin—breast cancer	2.27e-05	0.000126	CcSEcCtD
Etravirine—Dizziness—Doxorubicin—breast cancer	2.22e-05	0.000123	CcSEcCtD
Etravirine—Nausea—Epirubicin—breast cancer	2.15e-05	0.000119	CcSEcCtD
Etravirine—Vomiting—Doxorubicin—breast cancer	2.13e-05	0.000118	CcSEcCtD
Etravirine—Rash—Doxorubicin—breast cancer	2.11e-05	0.000117	CcSEcCtD
Etravirine—Dermatitis—Doxorubicin—breast cancer	2.11e-05	0.000117	CcSEcCtD
Etravirine—Headache—Doxorubicin—breast cancer	2.1e-05	0.000116	CcSEcCtD
Etravirine—Nausea—Doxorubicin—breast cancer	1.99e-05	0.00011	CcSEcCtD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—breast cancer	8.26e-06	0.000112	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	8.22e-06	0.000111	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ESRRA—breast cancer	8.02e-06	0.000108	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ANGPTL4—breast cancer	8.02e-06	0.000108	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—MED12—breast cancer	8.02e-06	0.000108	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—DPYD—breast cancer	8.02e-06	0.000108	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	7.95e-06	0.000108	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ALDOA—breast cancer	7.89e-06	0.000107	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—MED12—breast cancer	7.82e-06	0.000106	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—DPYD—breast cancer	7.82e-06	0.000106	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ALDOA—breast cancer	7.7e-06	0.000104	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NCOA3—breast cancer	7.66e-06	0.000104	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SLC2A2—breast cancer	7.61e-06	0.000103	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HADHB—breast cancer	7.6e-06	0.000103	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GPI—breast cancer	7.6e-06	0.000103	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—breast cancer	7.53e-06	0.000102	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	7.53e-06	0.000102	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NCOA3—breast cancer	7.48e-06	0.000101	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CPT1A—breast cancer	7.45e-06	0.000101	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—MTR—breast cancer	7.45e-06	0.000101	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ABCG2—breast cancer	7.45e-06	0.000101	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SLC2A2—breast cancer	7.42e-06	0.0001	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—DPYD—breast cancer	7.31e-06	9.89e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—MED12—breast cancer	7.31e-06	9.89e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—HPGDS—breast cancer	7.31e-06	9.89e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—MTR—breast cancer	7.27e-06	9.84e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CPT1A—breast cancer	7.27e-06	9.84e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ABCG2—breast cancer	7.27e-06	9.84e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—HBA1—breast cancer	7.26e-06	9.82e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ALDH1A1—breast cancer	7.25e-06	9.81e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ALDH7A1—breast cancer	7.25e-06	9.81e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ALDOA—breast cancer	7.19e-06	9.73e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—HPGDS—breast cancer	7.13e-06	9.65e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—HBA1—breast cancer	7.09e-06	9.59e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTT1—breast cancer	7.09e-06	9.59e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ACHE—breast cancer	7.09e-06	9.59e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NCOA3—breast cancer	6.98e-06	9.45e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—UMPS—breast cancer	6.95e-06	9.41e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PHGDH—breast cancer	6.95e-06	9.41e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—FHL2—breast cancer	6.95e-06	9.41e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NME1—breast cancer	6.95e-06	9.41e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ADSL—breast cancer	6.95e-06	9.41e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SLC2A2—breast cancer	6.94e-06	9.38e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ACHE—breast cancer	6.92e-06	9.36e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTT1—breast cancer	6.92e-06	9.36e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	6.86e-06	9.28e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HPSE—breast cancer	6.82e-06	9.22e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—LDHB—breast cancer	6.82e-06	9.22e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—BRIP1—breast cancer	6.82e-06	9.22e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—MTR—breast cancer	6.79e-06	9.19e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CPT1A—breast cancer	6.79e-06	9.19e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ABCG2—breast cancer	6.79e-06	9.19e-05	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	6.71e-06	9.08e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP17A1—breast cancer	6.71e-06	9.08e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—HPGDS—breast cancer	6.66e-06	9.01e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ENO1—breast cancer	6.64e-06	8.98e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PTGS1—breast cancer	6.64e-06	8.98e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—HBA1—breast cancer	6.62e-06	8.96e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	6.62e-06	8.95e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP17A1—breast cancer	6.55e-06	8.86e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—breast cancer	6.53e-06	8.84e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP2D6—breast cancer	6.51e-06	8.81e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PTGS1—breast cancer	6.48e-06	8.77e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ENO1—breast cancer	6.48e-06	8.77e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTA3—breast cancer	6.46e-06	8.75e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ABCC1—breast cancer	6.46e-06	8.75e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HMMR—breast cancer	6.46e-06	8.75e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTT1—breast cancer	6.46e-06	8.74e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ACHE—breast cancer	6.46e-06	8.74e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NCOA2—breast cancer	6.39e-06	8.65e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP2D6—breast cancer	6.36e-06	8.6e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PPARGC1B—breast cancer	6.26e-06	8.47e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NCOA2—breast cancer	6.24e-06	8.44e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—FASN—breast cancer	6.2e-06	8.39e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—BCHE—breast cancer	6.17e-06	8.35e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP17A1—breast cancer	6.12e-06	8.28e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SLC5A5—breast cancer	6.1e-06	8.25e-05	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	6.06e-06	8.2e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ENO1—breast cancer	6.06e-06	8.19e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PTGS1—breast cancer	6.06e-06	8.19e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—FASN—breast cancer	6.05e-06	8.19e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	6.03e-06	8.16e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—BCHE—breast cancer	6.03e-06	8.15e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	5.96e-06	8.06e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SLC5A5—breast cancer	5.95e-06	8.05e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP2D6—breast cancer	5.94e-06	8.03e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CA9—breast cancer	5.91e-06	8e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTA4—breast cancer	5.91e-06	8e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NQO1—breast cancer	5.89e-06	7.97e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SLC2A1—breast cancer	5.89e-06	7.97e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NCOA2—breast cancer	5.83e-06	7.89e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	5.77e-06	7.8e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTA2—breast cancer	5.76e-06	7.79e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GPX2—breast cancer	5.76e-06	7.79e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NQO1—breast cancer	5.75e-06	7.78e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SLC2A1—breast cancer	5.75e-06	7.78e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP3A4—breast cancer	5.74e-06	7.77e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	5.71e-06	7.73e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GPX4—breast cancer	5.69e-06	7.7e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SULT1A1—breast cancer	5.69e-06	7.7e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—FASN—breast cancer	5.65e-06	7.65e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP1B1—breast cancer	5.65e-06	7.64e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—BCHE—breast cancer	5.63e-06	7.62e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP3A4—breast cancer	5.61e-06	7.58e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SLC5A5—breast cancer	5.56e-06	7.52e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—IDH1—breast cancer	5.56e-06	7.52e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTA1—breast cancer	5.56e-06	7.52e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—HSP90AA1—breast cancer	5.54e-06	7.49e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP1B1—breast cancer	5.51e-06	7.46e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NAT2—breast cancer	5.5e-06	7.44e-05	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	5.48e-06	7.42e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—HSP90AA1—breast cancer	5.41e-06	7.31e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NCOA1—breast cancer	5.39e-06	7.29e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SLC2A1—breast cancer	5.37e-06	7.27e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NQO1—breast cancer	5.37e-06	7.27e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP19A1—breast cancer	5.31e-06	7.18e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—STK11—breast cancer	5.31e-06	7.18e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	5.26e-06	7.11e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NCOA1—breast cancer	5.26e-06	7.11e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP3A4—breast cancer	5.24e-06	7.09e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	5.21e-06	7.05e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—STK11—breast cancer	5.18e-06	7.01e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP19A1—breast cancer	5.18e-06	7.01e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP1B1—breast cancer	5.15e-06	6.97e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—HSP90AA1—breast cancer	5.05e-06	6.83e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4.98e-06	6.74e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—COMT—breast cancer	4.94e-06	6.68e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTP1—breast cancer	4.91e-06	6.65e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NCOA1—breast cancer	4.91e-06	6.65e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—HMOX1—breast cancer	4.84e-06	6.55e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—STK11—breast cancer	4.84e-06	6.55e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP19A1—breast cancer	4.84e-06	6.55e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ITPR1—breast cancer	4.83e-06	6.54e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—MED12—breast cancer	4.82e-06	6.52e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—DPYD—breast cancer	4.82e-06	6.52e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—COMT—breast cancer	4.82e-06	6.52e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTP1—breast cancer	4.79e-06	6.49e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ALDOA—breast cancer	4.74e-06	6.42e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—HMOX1—breast cancer	4.73e-06	6.4e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ITPR1—breast cancer	4.72e-06	6.38e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ABCB1—breast cancer	4.65e-06	6.29e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NCOA3—breast cancer	4.61e-06	6.23e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SLC2A2—breast cancer	4.57e-06	6.19e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—TYMS—breast cancer	4.57e-06	6.18e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4.54e-06	6.15e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PLA2G4A—breast cancer	4.51e-06	6.11e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NCOR1—breast cancer	4.51e-06	6.11e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTM1—breast cancer	4.51e-06	6.11e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—COMT—breast cancer	4.5e-06	6.09e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ABCG2—breast cancer	4.48e-06	6.06e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CPT1A—breast cancer	4.48e-06	6.06e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—MTR—breast cancer	4.48e-06	6.06e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTP1—breast cancer	4.48e-06	6.06e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—TYMS—breast cancer	4.46e-06	6.03e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—HMOX1—breast cancer	4.42e-06	5.98e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ITPR1—breast cancer	4.41e-06	5.96e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NCOR1—breast cancer	4.41e-06	5.96e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTM1—breast cancer	4.41e-06	5.96e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PLA2G4A—breast cancer	4.41e-06	5.96e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HPGDS—breast cancer	4.39e-06	5.94e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HBA1—breast cancer	4.37e-06	5.91e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GPX1—breast cancer	4.32e-06	5.85e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP1A1—breast cancer	4.28e-06	5.79e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ACHE—breast cancer	4.26e-06	5.77e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTT1—breast cancer	4.26e-06	5.77e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ERCC2—breast cancer	4.24e-06	5.74e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ABCB1—breast cancer	4.24e-06	5.74e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GPX1—breast cancer	4.22e-06	5.71e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP1A1—breast cancer	4.18e-06	5.65e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—TYMS—breast cancer	4.16e-06	5.63e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ERCC2—breast cancer	4.14e-06	5.6e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NCOR1—breast cancer	4.12e-06	5.57e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PLA2G4A—breast cancer	4.12e-06	5.57e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTM1—breast cancer	4.12e-06	5.57e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP17A1—breast cancer	4.03e-06	5.46e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ENO1—breast cancer	3.99e-06	5.4e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PTGS1—breast cancer	3.99e-06	5.4e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—MTHFR—breast cancer	3.99e-06	5.4e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GPX1—breast cancer	3.94e-06	5.33e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP2D6—breast cancer	3.92e-06	5.3e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP1A1—breast cancer	3.9e-06	5.28e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—MTHFR—breast cancer	3.89e-06	5.27e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ERCC2—breast cancer	3.87e-06	5.24e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NCOA2—breast cancer	3.84e-06	5.2e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—FASN—breast cancer	3.73e-06	5.04e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—BCHE—breast cancer	3.71e-06	5.02e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CAV1—breast cancer	3.68e-06	4.98e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SLC5A5—breast cancer	3.67e-06	4.96e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—MTHFR—breast cancer	3.64e-06	4.92e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CAV1—breast cancer	3.59e-06	4.86e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SLC2A1—breast cancer	3.54e-06	4.79e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NQO1—breast cancer	3.54e-06	4.79e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.52e-06	4.76e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP1B1—breast cancer	3.4e-06	4.59e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CAV1—breast cancer	3.36e-06	4.54e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PIK3CG—breast cancer	3.35e-06	4.53e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HSP90AA1—breast cancer	3.33e-06	4.51e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PIK3CG—breast cancer	3.27e-06	4.43e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NCOA1—breast cancer	3.24e-06	4.38e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.21e-06	4.34e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—STK11—breast cancer	3.19e-06	4.32e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP19A1—breast cancer	3.19e-06	4.32e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PIK3CG—breast cancer	3.06e-06	4.13e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—COMT—breast cancer	2.97e-06	4.02e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTP1—breast cancer	2.95e-06	4e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PIK3CD—breast cancer	2.95e-06	3.99e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HMOX1—breast cancer	2.91e-06	3.94e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ALB—breast cancer	2.91e-06	3.94e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ITPR1—breast cancer	2.91e-06	3.93e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PIK3CD—breast cancer	2.88e-06	3.89e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ALB—breast cancer	2.84e-06	3.84e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ABCB1—breast cancer	2.8e-06	3.78e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NOS3—breast cancer	2.78e-06	3.76e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—TYMS—breast cancer	2.75e-06	3.72e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NOS3—breast cancer	2.72e-06	3.67e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTM1—breast cancer	2.71e-06	3.67e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NCOR1—breast cancer	2.71e-06	3.67e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.71e-06	3.67e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PIK3CD—breast cancer	2.69e-06	3.63e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ALB—breast cancer	2.65e-06	3.59e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GPX1—breast cancer	2.6e-06	3.52e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP1A1—breast cancer	2.57e-06	3.48e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PIK3CB—breast cancer	2.57e-06	3.47e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ERCC2—breast cancer	2.55e-06	3.45e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PTGS2—breast cancer	2.55e-06	3.44e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NOS3—breast cancer	2.54e-06	3.43e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PIK3CB—breast cancer	2.51e-06	3.39e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PTGS2—breast cancer	2.48e-06	3.36e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—MTHFR—breast cancer	2.4e-06	3.25e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PIK3CB—breast cancer	2.34e-06	3.17e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PTGS2—breast cancer	2.32e-06	3.14e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PTEN—breast cancer	2.22e-06	3e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CAV1—breast cancer	2.21e-06	2.99e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PTEN—breast cancer	2.17e-06	2.93e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PTEN—breast cancer	2.02e-06	2.74e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PIK3CG—breast cancer	2.02e-06	2.73e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PIK3CD—breast cancer	1.77e-06	2.4e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ALB—breast cancer	1.75e-06	2.37e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NOS3—breast cancer	1.67e-06	2.26e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PIK3CA—breast cancer	1.57e-06	2.12e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PIK3CB—breast cancer	1.54e-06	2.09e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PTGS2—breast cancer	1.53e-06	2.07e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PIK3CA—breast cancer	1.53e-06	2.07e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PIK3CA—breast cancer	1.43e-06	1.93e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PTEN—breast cancer	1.33e-06	1.81e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—AKT1—breast cancer	1.28e-06	1.73e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—AKT1—breast cancer	1.25e-06	1.69e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—AKT1—breast cancer	1.17e-06	1.58e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PIK3CA—breast cancer	9.42e-07	1.27e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—AKT1—breast cancer	7.69e-07	1.04e-05	CbGpPWpGaD
